SCHEDULE 14A INFORMATION

Filed by the Registrant  [X]
Filed by a Party other than the Registrant

Check the appropriate box:

[ ]  Preliminary Proxy Statement

[ ]  Confidential,  for  Use  of the  Commission  Only  (as  permitted  by  Rule

[ ]  Definitive Proxy Statement

[ ]  Definitive Additional Materials

[X]  Soliciting Material Pursuant to Rule 14a-12

                                CARECENTRIC, INC.
                (Name of Registrant as Specified In Its Charter)

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[X]  No fee required.

     Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.

     (1)  Title of each class of securities to which transaction applies:


     (2)  Aggregate number of securities to which transaction applies:


     (3)  Per unit  price  or other  underlying  value of  transaction  computed
          pursuant to Exchange  Act Rule 0-11 (Set forth the amount on which the
          filing fee is calculated and state how it was determined):


     (4)  Proposed maximum aggregate value of transaction:


     (5)  Total fee paid:


[ ]  Fee paid previously with preliminary materials.

[ ]  Check box if any part of the fee is offset as provided by Exchange Act Rule
     0-11(a)(2)  and identify the filing for which the  offsetting  fee was paid
     previously.  Identify the previous filing by registration statement number,
     or the Form or Schedule and the date of its filing.

     (1)  Amount Previously Paid:


     (2)  Form, Schedule or Registration Statement No.:


     (3)  Filing Party:


     (4)  Date Filed:


                                 INVESTOR NOTICE

     If CareCentric proceeds with a proposed merger described  previously,  then
it will  file  with  the SEC a proxy  statement  and  other  relevant  documents
concerning  the merger.  Investors  of  CareCentric  are urged to read the proxy
statement when and if filed and any other relevant  documents filed with the SEC
because they will contain important information.  You will be able to obtain the
documents free of charge at the website maintained by the SEC at In
addition,  you may obtain  documents  filed with the SEC by CareCentric  free of
charge by requesting them in writing from Ana McGary at CareCentric,  Inc., 2625
Cumberland  Parkway,  Suite  310,  Atlanta,  GA 30339 or by  telephone  at (678)

     CareCentric,  its  directors  and  executive  officers and certain of their
employees  and the  investor  group  described  previously  may be  deemed to be
participants in the solicitation of proxies from the stockholders of CareCentric
in connection  with the merger,  if  consummated.  These  participants  may have
interests in the merger,  if  consummated,  including  interests  resulting from
holding  options or shares of CareCentric  common stock.  Information  about the
interests of  directors  and  executive  officers of  CareCentric,  the investor
group, and their ownership of securities of CareCentric will be set forth in the
proxy statement, when and if filed.

     Investors should ready the proxy statement carefully when and if it becomes
available before making any voting or investment decisions.

                                           JOHN R. FESTA
                                           PRESIDENT AND CEO
                                           (678)  264-4400


leading  provider  of  management  information  systems to the home  health care
community,  announced  today  that it has  received  a  revision  to the  merger
proposal  from an  investor  group  (Borden  Associates,  Inc.) led by its major
stockholder, John Reed, and his son, Stewart Reed, that could have the effect of
taking the company private.

     The revised  proposal  letter,  dated May 22, 2003,  increases  the maximum
total consideration that the investor group will pay the "smaller  stockholders"
of CareCentric (those holding less than 4,000 shares) from $450,000 to $550,000,
without  any  reduction  for  transaction  expenses.  The  new  proposal  allows
CareCentric  until  June 13,  2003 to  decide  whether  to accept  the  proposed
transaction.  The increase in the maximum total  consideration to be paid by the
investor group follows negotiations between the Independent Special Committee of
CareCentric's Board and representatives of the investor group led by John Reed.

     Consistent with the original proposal,  the proposed transaction could have
the following potential effects:

o    The number of record holders could be reduced from  approximately  5,500 to
     approximately 200;

o    CareCentric  would be eligible to terminate the  registration of its common
     stock under the Securities Exchange Act of 1934, as amended;

o    If the  termination of the  registration of the common stock was completed,
     the common stock would no longer be quoted on the OTC Bulletin Board.

     CareCentric  provides  information  technology systems and services to over
1,500  customers.   CareCentric   provides   freestanding,   hospital-based  and
multi-office  home health care providers  (including  skilled  nursing,  private
duty,  home medical  equipment and supplies,  IV pharmacy and hospice)  complete
information  solutions  that enable these home care  operations  to generate and
utilize  comprehensive  and  integrated  financial,   operational  and  clinical
information.  With offices nationwide,  CareCentric is headquartered in Atlanta,

Note regarding Private Securities Litigation Reform Act: Statements made in this
press release which are not historical facts, including projections,  statements
of plans, objectives,  expectations, or future economic performance, are forward
looking  statements that involve risks and  uncertainties and are subject to the

safe harbor  created by the Private  Securities  Litigation  Reform Act of 1995.
CareCentric's future financial  performance could differ significantly from that
set forth herein,  and from the  expectations of management.  Important  factors
that could cause CareCentric's  financial  performance to differ materially from
past results and from those expressed in any forward looking statements include,
without  limitation,  the  inability  to obtain  additional  capital  resources,
variability in quarterly  operating  results,  customer  concentration,  product
performance and acceptance, long sales cycles, long and varying delivery cycles,
CareCentric's dependence on business partners, emerging technological standards,
risks   associated  with   acquisitions   and  the  risk  factors   detailed  in
CareCentric's  Registration  Statement on Form S-4 (File No. 333-96529) and from
time to time in  CareCentric's  periodic  reports filed with the  Securities and
Exchange Commission.  Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of their dates.

                             BORDEN ASSOCIATES, INC.
                              260 NORTH ELM STREET
                               WESTFIELD, MA 01085
                                TEL: 413-564-5768
                                FAX: 413-564-5814

                                  May 22, 2003

Board of Directors
CareCentric, Inc.
Suite 310, 2625 Cumberland Parkway
Atlanta, GA 30339

     Re:  Proposal from Borden Associates,  Inc. ("BORDEN"),  Messrs. John Reed,
          Stuart  Reed,  and  James  Burk  (the  "INVESTORS")  to the  Board  of
          Directors of CareCentric, Inc. ("CARECENTRIC") dated January 28, 2003,
          as amended  by the letter  from  Borden to the Board of  Directors  of
          CareCentric dated April 23, 2003 (the "PROPOSAL")


     On behalf of Borden and the Investors,  I hereby amend the paragraph in the
Proposal entitled "Funding" as follows:

         "The  Investors  will  fund the  purchase  of  shares  from  the  Small
         Stockholders by investing in Borden,  immediately  prior to the Merger,
         an amount  equal to the Total Cash  Consideration;  provided,  however,
         that the Investors shall not be obligated to invest an amount in excess
         of $550,000, excluding amounts needed by Borden for expenses related to
         the transaction."

     As so amended, the Proposal will be kept open until 5 p.m. (EST) on Friday,
June 13,  2003.  We reserve the right to modify or withdraw  the Proposal at any
time prior to the execution and delivery of the definitive  merger  agreement in
the event that we become aware of any facts or circumstances  that we determine,
in our sole  discretion,  make  such  action  appropriate.  We will not have any
obligation  to  CareCentric  or its  stockholders  with  respect to the Proposal
unless and until we execute and deliver a  definitive  merger  agreement,  which
must be in form and content satisfactory to us in our sole discretion.

                                    Very truly yours,

                                    Borden Associates, Inc.

                                    /s/ John E. Reed

                                    John E. Reed, President